It is currently Wed Aug 27, 2014 8:18 pm

News News of ThisIsMS

Site map of ThisIsMS » Forum : ThisIsMS

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.

Bring back Harry Z

Dear all,

Harry, I was just trying to wind you up. You know me well enough by now. I had no idea that your surname really began with Z.

Arron - sorry if this caused you any problems. I never ever though that the post would be taken seriously.

My latest survey shows that 97% want the ban on Harry Z to be lifted. Welcome back Harry Z.

Read more : Bring back Harry Z | Views : 1944 | Replies : 5 | Forum : Tysabri (Antegren or Natalizumab)

Radio show will run more MS stories if you vote

I have a friend who does a radio show called Life Love & Health. It's on XM and a few NPR affiliates, as well as internationally on Voice of America and American Forces Network.

He's done a show or two about MS and I've been coaxing him to do more, so he agreed to put a poll on the show's website about autoimmune diseases to gauge interest. It's here, on the lower left:

Read more : Radio show will run more MS stories if you vote | Views : 1137 | Replies : 2 | Forum : General Discussion

Ban Harry Z

This is not my idea, but I have received a huge number of PMs asking me to raise this with Arron.

My recent survey of users of this site showed that of the 654 who voted, 86% want Harry Z banned from the thisisms site.

Harry is a menace. I have received a number of e-mails saying that Harry Z holds a substantial amount of stock in Teva, which accounts for his unrelenting attacks on ...
Read more : Ban Harry Z | Views : 2053 | Replies : 5 | Forum : Tysabri (Antegren or Natalizumab)

Rituximab / Rituxin

I have posted before on Rituximab which is being trialled in PP, SP and RR MS. The FDA has just approved Rituximab for Rheumatoid Arthritis. Rituximab targets the B cells which are now thought to be involved in MS. If the trials for MS do prove promising then I imagine approval might be speedier as it has been approved for eight years for cancer and now for RA. ...
Read more : Rituximab / Rituxin | Views : 2362 | Replies : 4 | Forum : Drug Pipeline

Who owns this site?

Begs the question who profits from this site? IF profit is involved - maybe the site is not as "unbiased" as one would think. hmmm...

Just out of curosity : Do a whois search on the domain name "" then do a search on the phone number listed
(480) 624-2599 I did... You'll get tons of listings -

While your at it do a search on (a link at the bottom of the main ...
Read more : Who owns this site? | Views : 2486 | Replies : 15 | Forum : General Discussion

testing for PML

Hi -

I've been reading through all the newly shared data and opinions on Tysabri and I have a question that maybe someone can answer. Does anyone know how the testing for PML is done? One description I read said they are taking "serial measurements of JC viral load" and I'm wondering just how those measurements are obtained.

Read more : testing for PML | Views : 1178 | Replies : 0 | Forum : Tysabri (Antegren or Natalizumab)

Reparative cells

Dear all,

MS news articles are thin on the ground at the moment. Tysabri is the dominant story (for Harry Z it must be like Christmas has come early). The following is about the possibility of repairing damage by blocking genes such as Nogo and Lingo 1. Who comes up with these names? I imagine a bored neurologist with some scrabble letters instead of getting on with the real business of working out what this ...
Read more : Reparative cells | Views : 912 | Replies : 1 | Forum : General Discussion

TYSABRI® Two-Year Phase III Published in New England Journal

1 March 2006
TYSABRI® Two-Year Phase III Multiple Sclerosis Clinical Trial Results and Safety Evaluation Published in New England Journal of Medicine; TYSABRI Currently Under Review with U.S. and European Regulatory Authorities
CAMBRIDGE, Mass. and DUBLIN, Ireland, Mar 01, 2006 (BUSINESS WIRE) -- Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) announced today that two-year results from the two Phase III clinical trials evaluating TYSABRI(R) (natalizumab) ...

Some Questions

In the past few weeks I've noted John has some problem with chocking more while eating. When I mention it of course he gets defensive and proclaims he just swallowed something the wrong way but it is happening a fair amount. I've noted him clearing his throat all the time as well but he says he must have a cold as it's just phlegm. It is unlike him to have that problem other than in ...
Read more : Some Questions | Views : 1172 | Replies : 4 | Forum : General Discussion

EMail to FDA/AC ie TEVA

I found this interesting post today on an messageboard.

" EMail to FDA/AC ie TEVA

by: uvauncduke 02/28/06 - This post has 86 recommendations

Dear Dr. Mosaddeghs:

I understand you represent CDER/FDA in the upcoming Peripheral and Central Nervous System Drugs Advisory Committee meeting regarding the multiple sclerosis drug Tysabri scheduled for March 7th and 8th.

As a physician I have both professional and personal contacts with patients stricken with multiple sclerosis. I greatly ...
Read more : EMail to FDA/AC ie TEVA | Views : 2922 | Replies : 14 | Forum : Tysabri (Antegren or Natalizumab)


Login  •  Register


Total posts 219531 • Total topics 22659 • Total members 14279

Contact us | Terms of Service